Age-related inflammatory cytokines and disease

Immunology and Allergy Clinics of North America

Volumn 23, Issue 1, 2003, Pages 15-39

  Brüünsgaard, Helle ^a   Pedersen, Bente Klarlund ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; SEX HORMONE; TUMOR NECROSIS FACTOR ALPHA;

AGE; AGED; AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CATABOLISM; COMORBIDITY; DISEASE ASSOCIATION; DISEASE MARKER; ENVIRONMENTAL FACTOR; HEALTH STATUS; HEREDITY; HORMONE ACTION; HUMAN; INFECTION; INFLAMMATION; LIFESTYLE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; THROMBOEMBOLISM;

AGED; AGING; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; INTERLEUKIN-6; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037331661     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(02)00056-5     Document Type: Review

References (166)

1. Dinarello CA. Role of interleukin-1 in infectious diseases. Immunol Rev 1992;127:119-46.
2. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997;18:428-32.
3. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993;77(6):1690-4.
4. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990; 75:40-7.
5. Matthys P, Mitera T, Heremans H, Van Damme J, Billiau A. Anti-γ interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect Immun 1995;63:1158-64.
6. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994;179:1529-37.
7. Pue CA, Mortensen RF, Marsh CB, Pope HA, Wewers MD. Acute phase levels of C-reactive protein enhance IL-1 β and IL-1ra production by human blood monocytes but inhibit IL-1β and IL-1ra production by alveolar macrophages. J Immunol 1996;156:1594-600.
8. Torres JM, Cardenas O, Vasquez A, Schlossberg D. Streptococcus pneumoniae bacteremia in a community hospital. Chest 1998;113:387-90.
9. Ahkee S, Srinath L, Ramirez J. Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis. South Med J 1997;90:296-8.
10. Gleckman R, Hibert D. Afebrile bacteremia: a phenomenon in geriatric patients. JAMA 1982; 248:1478-81.
11. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. Impaired production of proinflammatory cytokines in response to LPS stimulation in elderly humans. Clin Exp Immunol 1999;118:235-41.
12. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K, Horie T. Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin Exp Immunol 1996;106:120-6.
13. McLachlan JA, Serkin CD, Morrey KM, Bakouche O. Antitumoral properties of aged human monocytes. J Immunol 1995;154:832-43.
14. Wallace PK, Eisenstein TK, Meissler-JJ J, Morahan PS. Decreases in macrophage mediated antitumor activity with aging. Mech Ageing Dev 1995;77:169-84.
15. Bruley RM, Vergnon I. Interleukin-1 synthesis and activity in aged mice. Mech Ageing Dev 1984;24:247-64.
16. Effros RB, Svoboda K, Walford RL. Influence of age and caloric restriction on macrophage IL-6 and TNF production. Lymphokine Cytokine Res 1991;10:347-51.
17. Bradley SF, Vibhagool A, Kunkel SL, Kauffman CA. Monokine secretion in aging and protein malnutrition. J Leukoc Biol 1989;45:510-4.
18. Davila DR, Edwards CK, Arkins S, Simon J, Kelley KW. Interferon-γ-induced priming for secretion of superoxide anion and tumor necrosis factor-α declines in macrophages from aged rats. FASEB J 1990;4:2906-II.
19. Inamizu T, Chang MP, Makinodan T. Influence of age on the production and regulation of interleukin-1 in mice. Immunology 1985;55:447-55.
20. Roubenoff R, Harris TB, Abad LW, Wilson PF, Dallal GE, Dinarello CA. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998;53:M20-6.
21. Kauffman CA. Endogenous pyrogen/interleukin-I production in aged rats. Exp Gerontol 1986;21:75-8.
22. Rudd AG, Banerjee DK. Interleukin-1 production by human monocytes in ageing and disease. Age Ageing 1989;18:43-6.
23. Born J, Uthgenannt D, Dodt C, Nunninghoff D, Ringvolt E, Wagner T, et al. Cytokine production and lymphocyte subpopulations in aged humans: an assessment during nocturnal sleep. Mech Ageing Dev 1995;84:113-26.
24. Riancho JA, Zarrabeitia MT, Amado JA, Olmos JM, Gonzalez MJ. Age-related differences in cytokine secretion. Gerontol 1994;40:8-12.
25. Zhou D, Chrest FJ, Adler W, Munster A, Winchurch RA. Increased production of TGF-β and II-6 by aged spleen cells. Immunol Lett 1993;36:7-11.
26. Gabriel P, Cakman I, Rink L. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol 2002;37:235-47.
27. Fagiolo U, Cossarizza A, Scala E, Fanales BE, Ortolani C, Cozzi E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993;23:2375-8.
28. Saurwein-Teissl M, Blasko I, Zisterer K, Neuman B, Grubeck-Loebensten B. An imbalance between pro- and anti-inflammatory cytokines, a characteristic feature of old age. Cytokine 2000;12:1160-1.
29. O'Mahony L, Holland J, Jackson J, Feighery C, Hennessy TPJ, Mealy K. Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production. Clin Exp Immunol 1998;113:213-9.
30. McNerlan SE, Rea IM, Alexander HD. A whole blood method for measurement of intracellular TNF-α, IFN-γ and IL-2 expression in stimulated CD3+ lymphocytes: differences between young and elderly subjects. Exp Gerontol 2002;37:227-34.
31. Krabbe K, Bruunsgaard H, Hansen CM, Moller K, Fonsmark L, Quist J, et al. Aging is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 2001; 8:333-8.
32. Bruunsgaard H, Skinhøj P, Quist J, Pedersen BK. Elderly humans show prolonged in vivo inflammatory activity during Pneumococcal infections. J Infect Dis 1999;180:551-4.
33. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. A high plasma concentration of TNF-α is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 1999;54:M357-64.
34. Bruunsgaard H, Skinhøj P, Pedersen AN, Schroll M, Pedersen BK. Ageing, TNF-α and atherosclerosis. Clin Exp Immunol 2000;121:255-60.
35. Catania A, Airaghi L, Motta P, Manfredi MG, Annoni G, Pettenati C, et al. Cytokine antagonists in aged subjects and their relation with cellular immunity. J Gerontol A Biol Sci Med Sci 1997;52:B93-7.
36. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, et al. Advancing age and insulin resistance: role of plasma tumor necrosis factor-α. Am J Physiol Endocrinol Metab 1998;38:E294-9.
37. Cohen HJ, Pieper CF, Harris T, Rao KK, Currie MS. The association of plasma IL-6 levels with functional disability in community dwelling elderly. J Gerontol A Biol Sci Med Sci 1997;52: M201-8.
38. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J, et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998;83: 2012-7.
39. Ballou SP, Lozanski FB, Hodder S, Rzewnicki DL, Mion LC, Sipe JD, et al. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing 1996;25: 224-30.
40. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 1993;41:176-81.
41. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984;28:47-55.
42. Baggio G, Donazzan S, Monti D, Mari D, Martini S, Gabelli C, et al. Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J 1998;12: 433-7.
43. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000;51:245-70.
44. Gallagher D, Ruts E, Visser M, Heshka S, Baumgartner RN, Wang J, et al. Weight stability masks sarcopenia in elderly men and women. Am J Physiol Endocrinol Metab 2000;279: E366-75.
45. Dandona P, Weinstock R, Thusu K, AbdelRahman E, Aljada A, Wadden T. Tumor necrosis factor-α in sera of obese patients: Fall with weight loss. J Clin Endocrinol Metab 1998;83:2907-10.
46. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998;83:847-50.
47. Kem PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745-51.
48. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997;82:4196-200.
49. Garaulet M, Perex-Llamas F, Fuente T, Zamora S, Tebar FJ. Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-α, sex hormone-binding globulin and sex hormones. Eur J Endocrinol 2000;143:657-66.
50. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. TNF-α, leptin, and lymphocyte function in human aging. Life Sci 2000;67:2721-31.
51. Abrutyn E, Mossey J, Levison M, Boscia J, Pitsakis P, Kaye D. Epidemiology of asymptomatic bacteriuria in elderly women. J Am Geriatr Soc 1991;39:388-93.
52. Meurman JH, Pajukoski H, Snellman S, Zeiler S, Sulkava R. Oral infections in home-living elderly patients admitted to an acute geriatric ward. J Dent Res 1997;76:1271-6.
53. Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 2000;181(suppl):S402-10.
54. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 1993;14(suppl):57-61.
55. Megraud F, Brassens RM, Denis F, Belbouri A, Hoa DQ. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 1989;27:1870-3.
56. Crossley KB, Peterson PK. Infections in the elderly. Clin Infect Dis 1996;22:209-15.
57. Priø TK, Bruunsgaard H, Roge B, Skinhoj P, Pedersen BK. Asymtomatic bacteriuria in elderly humans is associated with increased levels of circulating TNF receptors. Exp Gerontol 2002;37: 693-9.
58. Rosenfeld ME, Blessing E, Lin TM, Moazed TC, Campbell LA, Kuo C. Chlamydia, inflammation, and atherogenesis. J Infect Dis 2000;181(suppl):S492-7.
59. Netea MG, Selzman CH, Kullberg BJ, Galama JM, Weinberg A, Stalenhoef AF, et al. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 2000;30:541-9.
60. Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 1996;64:4872-5.
61. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydiapneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 1998;19:721-7.
62. Geng Y, Berencsi K, Gyulai Z, Valyi-Nagy T, Gonczol E, Trinchieri G. Roles of interleukin-12 and γ interferon in murine Chlamydia pneumoniae infection. Infect Immun 2000;68: 2245-53.
63. Bruunsgaard H, Østergaard L, Andersen-Ranberg K, Jeune B, Pedersen BK. Proinflammatory cytokines, antibodies to Chlamydia pneumoniae and age-associated diseases in Danish centenarians-is there a link? Scand J Infect Dis 2002;34:493-9.
64. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002;89:1117-9.
65. Schroll M, Jorgensen T, Ingerslev J. The Glostrup Population Studies, 1964-1992. Dan Med Bull 1992;39:204-7.
66. Andersen-Ranberg K, Schroll M, Jeune B. Healthy centenarians do not exist, but autonomous centenarians do: a population-based study of morbidity among Danish centenarians. J Am Geriatr Soc 2001;49:900-8.
67. Peeters AC, Netea MG, Janssen MC, Kullberg BJ, Van der Meer JW, Thien T. Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest 2001;31:31-6.
68. Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 1998;31:643-8.
69. Dorffel Y, Latsch C, Stuhlmuller B, Schreiber S, Scholze S, Burmester GR, et al. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension 1999;34: 113-7.
70. Peeters AC, Netea MG, Kullberg BJ, Thien T, Van der Meer JW. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 1998; 94:376-9.
71. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113: 401-6.
72. Olivieri F, Bonafe M, Cavallone L, Giovagnetti S, Marchegiani F, Cardelli M, et al. The -174 C/G locus affects in vitro/in vivo IL-6 production during aging. Exp Gerontol 2002;37: 309-14.
73. Collins JS, Perry RT, Watson Jr. B, Harrell LE, Acton RT, Blacker D, et al. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet 2000;96:823-30.
74. McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, et al. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor α and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 2001;357:436-9.
75. Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Tumour necrosis factor-α gene promoter polymorphism and decreased insulin resistance. Diabetologia 1998;41:430-4.
76. Bouma G, Crusius JB, Oudkerk PM, Kolkman JJ, von Blomberg BM, Kostense PJ, et al. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles: relevance for inflammatory bowel disease. Scand J Immunol 1996;43:456-63.
77. Vinasco J, Beraun Y, Nieto A, Fraile A, Mataran L, Pareja E, et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997;49:74-8.
78. Bonafe M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 2001;31:2357-61.
79. Wang XY, Hurme M, Jylha M, Hervonen A. Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-α genes in Finnish nonagenarians. Mech Ageing Dev 2001;123:29-38.
80. Kilpinen S, Hulkkonen J, Wang XY, Hurme M. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw 2001;12:62-8.
81. Vaupel JW, Carey JR, Christensen K, Johnson TE, Yashin AI, Holm NV, et al. Biodemographic trajectories of longevity. Science 1998;280:855-60.
82. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
83. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000;102:3060-7.
84. Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D. Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest 1999;29:758-69.
85. Kotler DP. Cachexia. Ann Intern Med 2000;133:622-34.
86. Pacifici R. Aging and cytokine production. Calcif Tissue Int 1999;65:345-51.
87. Perry RT, Collins JS, Wiener H, Acton R, Go RC. The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging 2001;22:873-83.
88. Dobbs RJ, Charlett A, Purkiss AG, Dobbs SM, Weller C, Peterson DW. Association of circulating TNF-α and IL-6 with ageing and parkinsonism. Acta Neurol Scand 1999;100: 34-41.
89. Andersen-Ranberg K, Vasegaard L, Jeune B. Dementia is not inevitable. A population-based study of Danish Centenarians. J Gerontol 2001;56B:152-9.
90. Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B, et al. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett 1991;129:318-20.
91. Kalman J, Juhasz A, Laird G, Dickens P, Jardanhazy T, Rimanoczy A, et al. Serum interleukin 6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand 1997;96:236-40.
92. Solerte SB, Fioravanti M, Pascale A, Ferrari E, Govoni S, Battaini F. Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation. Neurobiol Aging 1998;19:191-9.
93. Huberman M, Shalit F, Roth DI, Gutman B, Brodie C, Kott E, et al. Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage. J Neuroimmunol 1994;52:147-52.
94. Huberman M, Sredni B, Stem L, Kott E, Shalit F. IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease. J Neurol Sci 1995; 130:161-4.
95. Shalit F, Sredni B, Stem L, Kott E, Huberman M. Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients. Neurosci Lett 1994; 174:130-2.
96. Teunissen CE, de Vente J, Steinbusch HW, De Bruijn C. Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol Aging 2002;23:485-508.
97. t'Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345:1515-21.
98. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.
99. Tarkowski E, Blennow K, Wallin A, Tarkowski A. Intracerebral production of tumor necrosis factor-α a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 1999;19:223-30.
100. Lue LF, Walker DG, Rogers J. Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging 2001;22:945-56.
101. Vandenabeele P, Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated "acute phase response" in the brain? Immunol Today 1991;12:217-9.
102. Venters HD, Broussard SR, Zhou JH, Bluthe RM, Freund GG, Johnson RW, et al. Tumor necrosis factor(α) and insulin-like growth factor-I in the brain: is the whole greater than the sum of its parts? J Neuroimmunol 2001;119:151-65.
103. Utsuyama M, Hirokawa K. Differential expression of various cytokine receptors in the brain after stimulation with LPS in young and old mice. Exp Gerontol 2002;37:411-20.
104. Pan W, Kastin AJ. TNFα transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol 2002;174:193-200.
105. Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 2002;23:831-4.
106. Belmin J, Bernard C, Corman B, Merval R, Esposito B, Tedgui A. Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats. Am J Physiol 1995; 268:H2288-93.
107. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982;91:686-93.
108. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis 1981; 34:261-9.
109. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997;131:115-25.
110. Postiglione A, Cicerano U, Gallotta G, Gnasso A, Lamenza F, Rubba P, et al. Prevalence of peripheral arterial disease and related risk factors in elderly institutionalized subjects. Gerontol 1992;38:330-7.
111. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study: Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993;88:837-45.
112. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991;87:119-28.
113. Criqui MH, Coughlin SS, Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation 1985;72:768-73.
114. Streit WJ, Sparks DL. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J Mol Med 1997;75:130-8.
115. Grammas P, Ovase R. Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer's disease brain. Am J Pathol 2002;160:1583-7.
116. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-4.
117. Skoog T, Dichtl W, Boquist S, Skoglund-Andersson C, Karpe F, Tang R, et al. Plasma tumour necrosis factor-α and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J 2002;23:376-83.
118. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149-53.
119. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997;96:3042-7.
120. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 1999;10:27-39.
121. Grunfeld C, Palladino MA. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. Adv Intern Med 1990;35:45-71.
122. Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1998;18:1199-202.
123. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol 2001;115: 3-12.
124. Metzger S, Hassin T, Barash V, Pappo O, Chajek-Shaul T. Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor. Am J Physiol Endocrinol Metab 2001;281:E957-65.
125. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin action and age: European Group for the Study of Insulin Resistance (EGIR). Diabetes 1996;45:947-53.
126. Hotamisligil GS. The role of TNF-α and TNF receptors in obesity and insulin resistance. J Intern Med 1999;245:621-5.
127. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
128. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999;353:1649-52.
129. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002;8:75-9.
130. Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999;130:945-50.
131. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57:M326-32.
132. Reid MB, Li YP. Tumor necrosis factor-α and muscle wasting: a cellular perspective. Respir Res 2001;2:269-72.
133. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889-96.
134. Mooradian AD, Reed RL, Osterweil D, Scuderi P. Detectable serum levels of tumor necrosis factor α may predict early mortality in elderly institutionalized patients. J Am Geriatr Soc 1991; 39:891-4.
135. Andersen K, Nybo H, Gaist D, Petersen HC, McGue M, Jeune B, et al. Cognitive impairment and mortality among nonagenarians: the Danish 1905 cohort survey. Dement Geriatr Cogn Disord 2002;13:156-63.
136. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WHJ, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-12.
137. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001;103:947-53.
138. Reuben DB, Cheh AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP, et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002;50:638-44.
139. Weijenberg MP, Feskens EJ, Souverijn JH, Kromhout D. Serum albumin, coronary heart disease risk, and mortality in an elderly cohort. Epidemiology 1997;8:87-92.
140. Rosenthal AJ, McMurtry CT, Sanders KM, Jacobs M, Thompson D, Adler RA. The soluble interleukin-2 receptor predicts mortality in older hospitalized men. J Am Geriatr Soc 1997; 45:1362-4.
141. Richards C, Gauldie J. Role of cytokines in the acute-phase response. In: Aggarwal BB, Puri RK, editors. Human cytokines: their roles in disease and therapy. Cambridge, MA: Blackwell Science; 1995. p. 253-69.
142. Ettinger-WH J, Sun WH, Binkley N, Kouba E, Ershler W. Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys. J Gerontol A Biol Sci Med Sci 1995; 50:M137-40.
143. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 2000;80:1055-81.
144. Pedersen BK, Steensberg A, Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol 2001;536:329-37.
145. Ostrowski K, Rohde T, Zacho M, Asp S, Pedersen BK. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 1998;508:949-53.
146. Ostrowski K, Hermann C, Bangash A, Schjerling P, Nielsen JN, Pedersen BK. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol 1998;513: 889-94.
147. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999;515:287-91.
148. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Chemokines are elevated in plasma after strenuous exercise in humans. Eur J Appl Physiol 2001;84:244-5.
149. Bruunsgaard H, Galbo H, Halkjaerkristensen J, Johansen TL, MacLean DA, Pedersen BK. Exercise induced increase in serum interleukin 6 in humans is related to muscle damage. J Physiol 1997;499:833-41.
150. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund PB. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 2000;529:237-42.
151. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, et al. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 2001;15:2748-50.
152. Febbraio MA, Steensberg A, Walsh R, Koukoulas I, van Hall G, Saltin B, et al. Reduced glycogen availability is associated with an elevation in HSP72 in contracting human skeletal muscle. J Physiol 2002;538:911-7.
153. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, et al. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 2001;537:633-9.
154. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002;16:1335-47.
155. Grip O, Janciauskiene S, Lindgren S. Pravastatin down-regulates inflammatory mediators in human monocytes in vitro. Eur J Pharmacol 2000;410:83-92.
156. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001;7:687-92.
157. Kurakata S, Kada M, Shimada Y, Komai T, Nomoto K. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro. Immunopharmacology 1996;34:51-61.
158. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000;6:1399-402.
159. Palinski W. Immunomodulation: a new role for statins? Nat Med 2000;6:1311-2.
160. LaRosa JC. Pleiotropic effects of statins and their clinical significance. Am J Cardiol 2001; 88:291-3.
161. Kothe H, Dalhoff K, Rupp J, Muller A, Kreuzer J, Maass M, et al. Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. Circulation 2000;101:1760-3.
162. Sadeghi MM, Collinge M, Pardi R, Bender JR. Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: involvement of an inhibitory G protein. J Immunol 2000;165:2712-8.
163. Ferro D, Parrotto S, Basili S, Alessandri C, Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol 2000; 36:427-31.
164. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000;6:435-42.
165. Zhang F, Yu W, Hargrove JL, Greenspan P, Dean RG, Taylor EW, et al. Inhibition of TNF-α induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis 2002; 161:381-6.
166. Pedersen M, Brüünsgaard H, Weis N, Hendel HW, Andreassen BU, Eldrup E, et al. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mechanism of Ageing and Development 2002, in press.